论文部分内容阅读
为验证血脂康对Ⅱ型糖尿病合并高脂血症患者的临床疗效及安全性,我们于1998年8月～1999年2月对80例Ⅱ型糖尿病合并高脂血症患者进行了随机对照观察,现将结果报告如下。
To verify the clinical efficacy and safety of Xuezhikang in patients with type II diabetes and hyperlipidemia, we conducted a randomized controlled study in 80 patients with type II diabetes mellitus and hyperlipemia from August 1998 to February 1999, The results reported below.